CereVasc raises $85M as specialist medtech keeps attracting capital
CereVasc raised an $85M Series C, showing continued investor interest in specialist medical devices with clear clinical use cases.
CereVasc has raised an $85M Series C, giving specialist medtech another sizeable funding signal.
What happened
The company is developing medical device technology for a focused clinical area, where product development is complex but the need can be very clear.
Why it matters
Medtech funding can be harder than pure software, but strong clinical use cases still attract capital. Investors tend to like categories where the problem is specific, the buyer is known, and the patient impact is obvious.
The bigger picture
AI gets most of the spotlight, but healthcare hardware is still quietly moving forward. Sometimes the biggest innovation is not another app — it is a better tool inside the clinic.